|
29 Sep 2020 |
Altimmune Presents Highlights of Intranasal COVID-19 Vaccine and Therapeutic Programs – AdCOVID™ and T-COVID™ – at the World Vaccine Congress
|
|
29 Sep 2020 |
Imvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
|
|
28 Sep 2020 |
COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
|
|
28 Sep 2020 |
INOVIO reports FDA partial clinical hold for planned Phase 2 / 3 trial of COVID-19 vaccine candidate INO-4800
|
|
25 Sep 2020 |
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials
|
|
25 Sep 2020 |
Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer
|
|
25 Sep 2020 |
Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis
|
|
25 Sep 2020 |
Clover Biopharmaceuticals Announces Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate
|
|
25 Sep 2020 |
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
|
|
23 Sep 2020 |
Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
|
|
23 Sep 2020 |
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
|
|
23 Sep 2020 |
St. Louis-based Precision Virologics and India's Biotech leader Bharat Biotech obtain rights to intranasal COVID-19 vaccine technology
|
|
21 Sep 2020 |
OSE Immunotherapeutics Presents Positive Step-1 Phase 3 Results for Tedopi® in NSCLC at the European Society for Medical Oncology Virtual Congress 2020
|
|
18 Sep 2020 |
Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-19
|
|
16 Sep 2020 |
Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101
|
|
14 Sep 2020 |
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
|
|
13 Sep 2020 |
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
|
|
12 Sep 2020 |
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
|
|
10 Sep 2020 |
Axon Announces Positive Pre-Clinical Results for its Peptide Vaccine (ACvac1) Against Novel Coronavirus
|
|
10 Sep 2020 |
Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19
|
|
10 Sep 2020 |
Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers
|
|
10 Sep 2020 |
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
|
|
09 Sep 2020 |
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine, Including Pivotal Trial
|
|
09 Sep 2020 |
Enterome - First Patient Dosed in a Phase 1/2 Trial with EO2401, an Innovative 'OncoMimic' based Immunotherapy Candidate Targeting Adrenal Tumors
|
|
09 Sep 2020 |
Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate
|
